[Frontiers in Bioscience 3, d961-972, September 1, 1998]
Reprints
PubMed
CAVEAT LECTOR



Table of Conents
Previous Section Next Section

PHYSIOLOGIC IMPORTANCE OF PROTEIN PHOSPHATASE INHIBITORS

Carey J. Oliver and Shirish Shenolikar

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710

Received 8/14/98 Accepted 8/20/98

6. REFERENCES

  1. Ingebritsen, T. S.: Phosphotyrosyl-protein phosphatases. II. Identification and characterization of two heat-stable protein inhibitors. J Biol Chem 264, 7754-7759 (1989)

  2. Shenolikar, S.: Protein serine/threonine phosphatases-New avenues for cell regulation. Ann Rev Cell Biol 10, 55-86 (1994)

  3. Wera, S. & B. A. Hemmings: Protein serine/threonine phosphatases. Biochem J 311, 17-29 (1994)

  4. Cohen, P.: The structure and regulation of protein phosphatases. Ann Rev Biochem 58, 453-508 (1989)

  5. Brautigan, D. L., J. Sunwoo, J. C. Labbe, A. Fernandez & N. J. Lamb: Cell cycle oscillation of phosphatase inhibitor-2 in rat fibroblasts coincident with p34cdc2 restriction. Nature 344, 74-78 (1990)

  6. Gonzalez, G. A. & M. R. Montminy: Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680 (1989)

  7. Bito, H., K. Deisseroth & R. W. Tsien: CREB phosphorylation and dephosphorylation: a Ca2+- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87, 1203-1214 (1996)

  8. Hagiwara, M., A. Alberts, P. Brindle, J. Meinkoth, J. Feramisco, T. Deng, M. Karin, S. Shenolikar & M. Montminy: Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell 70, 105-113 (1992)

  9. Anderson, K. A., T. J. Ribar, M. Illario & A. R. Means: Defective survival and activation of thymocytes in transgenic mice expressing a catalytically inactive form of Ca2+/calmodulin-dependent protein kinase IV. Mol Endo 11, 725-737 (1997)

  10. Alberts, A. S., M. Montminy, S. Shenolikar & J. R. Feramisco: Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Mol Cell Bio 14, 4398-4407 (1994)

  11. Sherr, C. J.: Cancer cell cycles. Science 274, 1672-1677 (1996)

  12. Ludlow, J. W., C. L. Glendening, D. M. Livingston & J. A. DeCaprio: Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Bio 13, 367-372 (1993)

  13. Alberts, A. S., A. M. Thorburn, S. Shenolikar, M. C. Mumby & J. R. Feramisco: Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc Natl Acad Sci USA 90, 388-392 (1993)

  14. Berndt, N., M. Dohadwala & C. W. Liu: Constitutively active protein phosphatase 1 alpha causes Rb-dependent G1 arrest in human cancer cells. Curr Biol 7, 375-386 (1997)

  15. Allen, P. B., Y. G. Kwon, A. C. Nairn & P. Greengard: Isolation and characterization of PNUTS, a putatitve protein phosphatase 1 nuclear targeting subunit. J Biol Chem 273, 4089-4095 (1998)

  16. Favre, B., S. Zolnierowicz, P. Turowski & B. A. Hemmings: The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem 269, 16311-16317 (1994)

  17. Li, M., H. Guo & Z. Damuni: Purification and characterization of two potent heat-stable inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 34, 1988-1996 (1995)

  18. Mulkey, R. M., S. Endo, S. Shenolikar & R. C. Malenka: Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369, 486-488 (1994)

  19. Liu, J., J. D. Farmer Jr., W. S. Lane, J. Friedman, I. Weissman & S. L. Schreiber: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815 (1991)

  20. Cardenas, M. E., C. Hemenway, R. S. Muir, R. Ye, D. Fiorentino & J. Heitman: Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO J 13, 5944-5957 (1994)

  21. Lai, M. M., P. E. Burnett, H. Wolosker, S. Blackshaw & S. H. Snyders: Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem 273, 18325-18331 (1998)

  22. Coghlan, V. M., B. A. Perrino, M. Howard, L. K. Langeberg, J. B. Hicks, W. M. Gallatin & J. D. Scott: Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267, 108-111 (1995)

  23. Aramburu, J., F. Garciacozar, A. Raghavan, H. Okamura, A. Rao & P. G. Hogan: Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol Cell 1, 627-637 (1998)

  24. Huang, F. L.& W. H. Glinsmann: Seperation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. Eur J Biochem 70, 419-426 (1976)

  25. Foulkes, J. G., S. J. Strada, P. J. Henderson & P. Cohen: A kinetic analysis of the effects of inhibitor-1 and inhibitor-2 on the activity of protein phosphatase-1. Eur J Biochem 132, 309-313 (1983)

  26. Aitken, A. & P. Cohen: Isolation and characterisation of active fragments of protein phosphatase inhibitor-1 from rabbit skeletal muscle. FEBS Lett 147, 54-58 (1982)

  27. Endo, S., X. Zhou, J. H. Connor, B. Wang & S. Shenolikar: Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor. Biochemistry 35, 5220-5228 (1996)

  28. Egloff, M. P., D. F. Johnson, G. Moorhead, P. T. Cohen, P. Cohen & D. Barford: Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J 16, 1876-1887 (1997)

  29. Aitken, A., T. Bilham & P. Cohen: Complete primary structure of protein phosphatase inhibitor-1 from rabbit skeletal muscle. Eur J Biochem 126, 235-246 (1982)

  30. Poulter, L., S. G. Ang, B. W. Gibson, D. H. Williams, C. F. Holmes, F, B, Caudwell, J. Pitcher & P. Cohen: Analysis of the in vivo phosphorylation state of rabbit skeletal muscle glycogen synthase by fast-atom-bombardment mass spectroscopy. Eur J Biochem 175, 497-510 (1988)

  31. Nakielny, S., D. G. Campbell & P. Cohen: The molecular mechanism by which adrenalin inhibits glycogen synthesis. Eur J Biochem 199, 713-722 (1991)

  32. Chan, C. P., S. J. McNall, E. G. Krebs & E. H. Fischer: Stimulation of protein phosphatase activity by insulin and growth factors in 3T3 cells. Proc Natl Acad Sci USA 85, 6257-6261 (1988)

  33. Printen, J. A., M. J. Brady & A. R. Saltiel: PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science 275, 1475-1578 (1997)

  34. Brady, M. J., A. C. Nairn & A. R. Saltiel: The regulation of glycogen synthase by protein phosphatase 1 in 3T3-L1 adipocytes. Evidence for a potential role for DARPP-32 in insulin action. J Biol Chem 272, 29698-29703 (1997)

  35. Malinow, R., H. Schulman & R. W. Tsien: Inhibition of post-synaptic PKC or CaMKII blocks induction but not expression of LTP. Science 245, 862-866 (1989)

  36. Grant, S. G., T. J. O’Dell, K. A. Karl, P. L. Stein, P. Soriano & E. R. Kandel: Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258, 1903-1910 (1992)

  37. Blitzer, R. D., J. H. Connor, G. P. Brown, T. Wong, S. Shenolikar, R. Iyengar & E. M. Landau: Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP. Science 280, 1940-1943 (1998)

  38. Huchon, D., R. Ozon & J. G. Demaille: Protein phosphatase-1 is involved in Xenopus oocyte maturation. Nature 294, 358-359 (1981)

  39. Walker, D. H., A. A. DePaoli-Roach & J. L. Maller: Multiple roles for protein phosphatase 1 in regulating the Xenopus early embryonic cell cycle. Mol Bio Cell 3, 687-698 (1992)

  40. Florio, T., B. A. Perrino & P. J. Stork: Cyclic 3,5 adenosine monophosphate and cyclosporin A inhibit cellular proliferation and serine/threonine protein phosphatase activity in pituitary cells. Endocrinology 137, 4409-4418 (1996)

  41. Neumann, J., R. C. Gupta, W. Schmitz, H. Scholz, A. C. Nairn & A. M. Watanabe: Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ Res 69, 1450-1457 (1991)

  42. Gupta, R. C., J. Neumann, A. M. Watanabe, M. Lesch & H. N. Sabbah: Evidence for the presence and hormonal regulation of protein phosphatase inhibitor-1 in ventricular cardiomyocites. Am J Phys 270, 1159-1164 (1996)

  43. Lindemann, J. & A Watanabe: Mechanisms of adrenergic and cholinergic regulation of myocardial contractility. In: Physiology and pathology of the heart. Ed: Sperelakis N, Kluwer Academic Publishers, ME 423-452 (1989)

  44. Chisholm, A. A. & P. Cohen: The myosin-bound form of protein phosphatase 1 (PP-1M) is the enzyme that dephosphorylates native myosin in skeletal and cardiac muscles. Biochem et Biophys Acta 971, 163-169 (1988)

  45. Walaas, S. I., D. W. Aswad & P. Greengard: A dopamine- and AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69-71 (1983)

  46. Hemmings, H. C. Jr., J. A. Girault, A. C. Nairn, G. Bertuzzi & P. Greengard: Distribution of protein phosphatase inhibitor-1 in brain and peripheral tissues of various species: comparison with DARPP-32. J Neurochem 59, 1053-1061 (1992)

  47. Stralfors, P., H. C. Hemmings Jr. & P. Greengard: Inhibitors of protein phosphatase-1. Inhibitor-1 of bovine adipose tissue and a dopamine- and cAMP-regulated phosphoprotein of bovine brain are identical. Eur J Biochem 180, 143-148 (1989)

  48. Aperia, A., A. Bertorello & I. Seri: Dopamine causes inhibition of Na+, K+-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 252, F39-45 (1987)

  49. Snyder, G. L., J. A. Girault, J. Y. Chen, A. J. Czernik, J. W. Kebabian, J. A. Nathanson & P. Greengard: Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. J Neurosci 12, 3071-3083 (1992)

  50. Desdouits, F., J. C. Siciliano, P. Greengard & J. A. Girault: Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. Proc Natl Acad Sci USA 92, 2682-2685 (1995)

  51. Halpain, S., J. A. Girault & P. Greengard: Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343, 369-372 (1990)

  52. Meister, B., J. Fryckstedt, M. Schalling, R. Cortes, T. Hokfelt, A. Aperia, H. C. Hemmings Jr., A. C. Nairn, M. Ehrlich & P. Greengard: Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and DA1-agonist-sensitive Na+, K+-ATPase in tubule cells of the kidney. Proc Natl Acad Sci USA 86, 8068-8072 (1989)

  53. Aperia, A., J. Fryckstedt, L. Svensson, H. C. Hemmings Jr, A. C. Nairn & P. Greengard: Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+, K+-ATPase activity in renal tubule cells. Proc Natl Acad Sci USA 88, 2798-2801 (1991)

  54. Holmes, C. F., J. Kuret, A. A. Chisholm & P. Cohen: Identification of the sites on rabbit skeletal muscle protein phosphatase inhibitor-2 phosphorylated by casein kinase-II. Biochem et Biophys Acta 870, 408-416 (1986)

  55. Depaoli-Roach, A. A.: Synergistic phosphorylation and activation of ATP-Mg-dependent phosphoprotein phosphatase by F A/GSK-3 and casein kinase II (PC0.7). J Biol Chem 259, 12144-12152 (1984)

  56. Park, I. K. & A. A. Depaoli-Roach: Domains of phosphatase inhibitor-2 involved in the control of the ATP-Mg-dependent protein phosphatase. J Biol Chem 269, 28919-28928 (1994)

  57. Bollen, M., A. A. DePaoli-Roach & W. Stalmans: Native cytosolic protein phosphatase-1 (PP-1S) containing modulator (inhibitor-2) is an active enzyme. FEBS Lett 344, 196-200 (1994)

  58. Alessi, D. R., A. J. Street, P. Cohen & P. T. W. Cohen: Inhibitor-2 functions like a chaperone to fold three expressed isoforms of mammalian protein phosphatase-1 into a conformation with the specificity and regulatory properties of the native enzyme. Eur J Biochem 213, 1055-1066 (1993)

  59. Mackintosh, C., A. J. Garton, A. McDonnell, D. Barford, P. T. W. Cohen, N. K. Tonks & P. Cohen: Further evidence that inhibitor-2 acts like a chaperone to fold PP1 into its native conformation. FEBS Lett 397, 235-238 (1996)

  60. Tung, H. Y., W. Wang & C. S. Chan: Regulation of chromosome segregation by Glc8p, a structural homolog of mammalian inhibitor 2 that functions as both an activator and an inhibitor of yeast protein phosphatase 1. Mol Cell Biol 15, 6064-6074 (1995)

  61. Kakinoki, Y., J. Somers & D. L. Brautigan: Multisite phosphorylation and the nuclear localization of phosphatase inhibitor 2-green fluorescent protein fusion protein during S phase of the cell growth cycle. J Biol Chem 272, 32308-32314 (1997)

  62. Vijayaraghavan, S., D. T. Stephens, K. Trautman, G. D. Smith, B. Khatra, E. F. da Cruz e Silva & P. Greengard: Sperm motility development in the epididymis is associated with decreased glycogen synthase kinase-3 and protein phosphatase 1 activity. Biol Reprod 54, 709-718 (1996)

  63. Beullens, M., A. Van Eynde, W. Stalmans & M. Bollen: The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei. J Biol Chem 267, 16538-16544 (1992)

  64. Van Eynde, A., S. Wera, M. Beullens, S. Torrekens, F. Van Leuven, W. Stalmans & M. Bollen: Molecular cloning of NIPP-1, a nuclear inhibitor of protein phosphatase-1, reveals homology with polypeptides involved in RNA processing. J Biol Chem 270, 28068-28074 (1995)

  65. Vulsteke, V., M. Beullens, E. Waelkens, W. Stalmans & M. Bollen: Properties and phosphorylation sites of baculovirus-expressed nuclear inhibitor of protein phosphatase-1 (NIPP-1). J Biol Chem 272, 32972-32978 (1997)

  66. Jagiello, I., M. Beullens, V. Vulsteke, S. Wera, B. Sohlberg, W. Stalmans, A. von Gabain & M. Bollen: NIPP-1, a nuclear inhibitory subunit of protein phosphatase-1, has RNA-binding properties. J Biol Chem 272, 22067-22071 (1997)

  67. Hirano, K., F. Erdodi, J. G. Patton & D. J. Hartshorne: Interaction of protein phosphatase type 1 with a splicing factor. FEBS Lett 389, 191-194 (1996)

  68. Beullens, M., W. Stalmans & M. Bollen: Characterization of a ribosomal inhibitory polypeptide of protein phosphatase-1 from rat liver. Eur J Biochem 239, 183-189 (1996)

  69. Eto, M., T. Ohmuri, M. Suzuki, K. furuya & F. Morita: A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem 118, 1104-1107 (1995)

  70. Eto, M., S. Senba, F. Morita & M. Yazawa: Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 410, 356-360 (1997)

  71. Li, M., A. Makkinje & Z. Damuni: Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 35, 6998-7002 (1996)

  72. Vaesen, M., B. W. Shitsu, H. Gotz, A. A. Lewa, T. Cole, B. Zimmerman, H. D. Kratzin & N. Hilschmann: Purification and characterization of two putative HLA class II associated proteins: PHAP-1 and PHAP-II. Biol Chem Hoppe-Seyler 357, 113-126 (1994)

  73. Li, M., A. Makkinje & Z. Damuni: The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 271, 11059-11062 (1996)

  74. Beresford, P. J., C. M. Kam, J. C. Powers & J. Lieberman: Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci USA 94, 9285-9290 (1997)

  75. Girault, J. A., R. Raisman-Vozari, Y. Agid & P. Greengard: Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. Proc Natl Acad Sci USA 86, 2493-2497 (1989)

  76. Fornerod, M., J. Boer, S. van Baal, M. Jaegle, M. von Lindern, K. G. Murti, D. Davis, J. Bonten, A. Buijs & G. Grosveld: Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene 10, 1739-1748 (1995)

  77. Kraemer, D., R. W. Wozniak, G. Blobel & A. Radu: The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci USA 91, 1519-1523 (1994)

  78. von Lindern, M., S. van Baal, J. Wiegant, A. Raap, A. Hagemeijer & G. Grosveld: Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3’ half to different genes: characterization of the set gene. Mol Cell Biol 12, 3346-3355 (1992)

  79. Miskin, J. E., C. C. Abrams, L. C. Goatley & L. K. Dixon: A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science 281, 562-565 (1998)

  80. Hemmings, H. C. Jr., P. Greengard, H. Y. Tung m& P. Cohen: DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505 (1984)